Caprioli, Flavio <br/><br/>
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.  [electronic resource] 

 -  Inflammatory bowel diseases   
 - 729-39 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1097/MIB.0b013e318280292b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antigens, CD--genetics<br/>Antigens, Differentiation, Myelomonocytic--genetics<br/>Apoptosis--drug effects<br/>Case-Control Studies<br/>Cell Differentiation--drug effects<br/>Cell Proliferation--drug effects<br/>Colitis, Ulcerative--drug therapy<br/>Crohn Disease--drug therapy<br/>Down-Regulation<br/>Endoscopy<br/>Female<br/>Gastrointestinal Agents--adverse effects<br/>Granulocyte-Macrophage Colony-Stimulating Factor--genetics<br/>Humans<br/>Infliximab<br/>Interleukin-17--genetics<br/>Intestinal Mucosa--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Microscopy, Fluorescence<br/>Middle Aged<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Wound Healing